About 50% to 70% of all lower extremity amputations are related to diabetes infection. And antibiotic therapy is routinely used for all infected wounds to reduce the mortality of diabetic foot. Here, we report a case of diabetic foot with acute and deep severe infection. During hospital therapy, we used negative pressure therapy and extensive debridement without systemic antibiotic application, and we successfully rescued a foot from amputation. Negative pressure therapy and extensive debridement are very important and effective methods to control infection and promote wound healing in diabetes foot.
SinghNArmstrongDGLipskyBA.Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217-228.
2.
BoultonAJVileikyteLRagnarson-TennvallGApelqvistJ.The global burden of diabetic foot disease. Lancet. 2005; 366:1719-1724.
3.
ApelqvistJBakkerKvan HoutumWHNabuurs-FranssenMHSchaperNC.International consensus on the diabetic foot and practical guidelines on the management and the prevention of the diabetic foot. Diabetes Metab Res Rev. 2000;16(suppl 1):S84-S92.
4.
ApelqvistJBakkerKvan HoutumWHSchaperNC.Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2008;24(suppl 1):S181-S187.
5.
ErstadBLMcIntyreKE.Prospective, randomized comparison of ampicillin/sulbactam and cefoxitin for diabetic foot infections. Vasc Endovasc Surg. 1997;31:419-426.
6.
LipskyBABakerPDLandonGCFernauR.Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clin Infect Dis. 1997;24:643-648.
7.
PrompersLHuijbertsMSchaperN. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51:1826-1834.
8.
MaghsoudiHSalehiFKhosrowshahiMKBaghaeiMNasirzadehMShamsR.Comparison between topical honey and mafenide acetate in treatment of burn wounds. Ann Burns Fire Disasters. 2011;24:132-137.
9.
KucanJOHeggersJP.The potential benefit of 5% sulfamylon solution in the treatment of Acinetobacter baumannii- contaminated traumatic war wounds. J Burns Wounds. 2005;4:e3.
10.
MorykwasMJSimpsonJPungerKArgentaAKremersLArgentaJ.Vacuum-assisted closure: state of basic research and physiologic foundation. Plast Reconstr Surg. 2006;117(7 suppl):121S-126S.
11.
LekasALazarisACDeliveliotisC. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue. Anticancer Res. 2006;26:2989-2993.
12.
SchoppmannSFFenzlASchindlM. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat. 2006;99:135-141.
13.
MorykwasMJArgentaLCShelton-BrownEIMcGuirtW.Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997;38:553-562.
14.
VikatmaaPJuutilainenVKuukasjärviPMalmivaaraA.Negative pressure wound therapy: a systematic review on effectiveness and safety. Eur J Vasc Endovasc Surg. 2008;36:438-448.
15.
RejzekAWeyerF.Der Einsatz des VACSystems in der Therapie von Ulcus cruris und diabetischer Gangrän. Acta Chir Austriaca. 1998;150(suppl):12-13.
16.
TentolourisNPetrikkosGVallianouN. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006;12:186-189.
17.
TentolourisNJudeEBSmirnofIKnowlesEABoultonAJ.Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med. 1999;16:767-771.
18.
DangCNPrasadYDBoultonAJJudeEB.Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med. 2003;20:159-161.
